本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AEON Biopharma

1.10
-0.3000-21.43%
盘后1.09-0.0100-0.91%19:53 EDT
成交量:88.93万
成交额:105.62万
市值:1,280.82万
市盈率:-2.76
高:1.41
开:1.34
低:1.03
收:1.40
52周最高:79.92
52周最低:0.3750
股本:1,164.38万
流通股本:819.63万
量比:1.28
换手率:10.85%
股息:- -
股息率:- -
每股收益(TTM):-0.3985
每股收益(LYR):77.74
净资产收益率:--
总资产收益率:-129.01%
市净率:-0.81
市盈率(LYR):0.01

数据加载中...

2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/24

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/19

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/08/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/08/01

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/28

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/27

重要事件披露

Form 8-K - Current report
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/21

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/21

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2023/07/20

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]